Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Looking ahead

No hearings or votes scheduled.

History

1. 2025
   1. Apr 28Pub. Ch. 295Latest
   2. Apr 28Effective date(s) 07/01/2025
   3. Apr 24Signed by Governor Bill Lee.Became Law
   4. Apr 16Transmitted to Governor for his action.To Governor
   5. Apr 14Signed by Senate SpeakerMajor
   6. Apr 10Signed by H. SpeakerMajor
   7. Apr 8Enrolled; ready for sig. of H. Speaker.Minor
   8. Apr 7H. adopted am. (Amendment 1 - HA0252)Major
   9. Apr 7Sponsor(s) Added.Minor
   10. Apr 7Passed H., as am., Ayes 92, Nays 1, PNV 0Passed Senate
   11. Apr 7Engrossed; ready for transmission to Sen.Minor
   12. Apr 7Received from House, Passed on First ConsiderationMinor
   13. Apr 7Senate substituted House Bill for companion Senate Bill.Major
   14. Apr 7Amendment withdrawn. (Amendment 1 - SA0095)
   15. Apr 7Passed Senate, Ayes 27, Nays 4Passed House
   16. Apr 3H. Placed on Regular Calendar for 4/7/2025
   17. Apr 2Placed on cal. Calendar & Rules Committee for 4/3/2025
   18. Apr 1Rec. for pass. if am., ref. to Calendar & Rules CommitteeMinor
   19. Mar 26Placed on cal. Health Committee for 4/1/2025
   20. Mar 25Action def. in Health Committee to 4/1/2025
   21. Mar 19Rec for pass if am by s/c ref. to Health CommitteeMinor
   22. Mar 19Placed on cal. Health Committee for 3/25/2025
   23. Mar 12Placed on s/c cal Health Subcommittee for 3/19/2025
   24. Feb 12P2C, ref. to Health CommitteeMinor
   25. Feb 12Assigned to s/c Health SubcommitteeMinor
   26. Feb 10Intro., P1C.Minor
   27. Feb 6Filed for introductionIntroduced